Stock SNNAQ SIENNA BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Sienna Biopharmaceuticals, Inc.

Equities

SNNAQ

US82622H1086

Delayed OTC Markets
Other stock markets
 02:22:47 2024-03-25 pm EDT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Sienna Biopharmaceuticals, Inc. -.--% -.--%
2021 Motion for Asset Sale Approved for Sienna Biopharmaceuticals, Inc. CI
2021 Avro Life Sciences, Inc. entered into an agreement to acquire Certain Assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $0.1 million. CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sienna Biopharmaceuticals, Inc. Announces Management Changes
CI
Sienna Biopharmaceuticals, Inc. Announces the Resignation of Robert Nelsen as Member of the Board
CI
Sienna Biopharmaceuticals, Inc. Appoints James M. Hindman to Board of Directors
CI
Sienna Biopharmaceuticals Announces Appointment of Caroline Van Hove as Chief Commercial Officer
CI
Sienna Biopharmaceuticals Establishes Corporate Advisory Board
CI
Sienna Biopharmaceuticals, Inc Appoints Erle Mast to its Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNNAQ Stock
  4. News Sienna Biopharmaceuticals, Inc.
  5. Insiders